|
|
|
|
Tevogen Bio Holdings Inc (NASDAQ: TVGN) |
|
Price: $1.2000
$-0.02 
-1.639%
|
| Day's High:
| $1.26
| Week Perf:
| -10.45 %
|
| Day's Low: |
$ 1.20 |
30 Day Perf: |
6.19 % |
| Volume (M): |
372 |
52 Wk High: |
$ 3.09 |
| Volume (M$): |
$ 446 |
52 Wk Avg: |
$1.07 |
| Open: |
$1.22 |
52 Wk Low: |
$0.26 |
|
|
| Market Capitalization (Millions $) |
176 |
| Shares
Outstanding (Millions) |
147 |
| Employees |
18 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-10 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Tevogen Bio Holdings Inc
Company Address: 15 Independence Boulevard Warren 7059 NJ
Company Phone Number: 838-6434 Stock Exchange / Ticker: NASDAQ TVGN
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Stock Market Announcement
Published Fri, May 2 2025 7:45 PM UTC
Tevogen Bio Holdings Inc. Responds to Rising Shareholder Interest in Direct Registration System (DRS) A New Chapter for Tevogen Bio Holdings Inc.Tevogen Bio Holdings Inc. (NASDAQ: TVGN), a burgeoning biotechnology company based in Warren, New Jersey, has recently garnered significant attention from its shareholders, particularly regarding the Direct Registration System (DRS)...
|
| Product Service News
Published Mon, Apr 28 2025 9:22 PM UTC
Tevogen Bio Projects $1 Billion in Oncology Revenue in Launch Year, Up to $14 Billion Over Five Years Tevogen Bio Holdings Inc. a biotech company based in Warren, New Jersey, has reaffirmed its ambitious revenue projections for its oncology pipeline, predicting topline revenues of $1 billion in the first year following product launches and a cumulative estimate of between $1...
|
| Contract
Published Tue, Apr 15 2025 6:49 PM UTC
April 15, 2025 Warren, N.J. In a significant advancement toward the future of precision medicine, Tevogen Bio Holdings Inc. has announced its collaboration with Databricks, Inc. a recognized leader in data, analytics, and artificial intelligence solutions. This partnership is centered around the accelerated development of PredicTcell, Tevogen Bio s innovative AI-driven tar...
|
| Product Service News
Published Thu, Apr 10 2025 10:28 AM UTC
Warren, N.J. April 9, 2025 In a significant move to enhance pharmaceutical manufacturing within the United States, Tevogen Bio Holdings Inc. (Nasdaq: ), a key player in innovative healthcare solutions, has announced the launch of its newest initiative, Tevogen Generics. This strategic effort is closely aligned with the national agenda of improving pharmaceutical affordabilit...
|
| Management Announcement
Published Fri, Feb 21 2025 8:29 PM UTC
Tevogen Bio?s First Trading Year: A Promising Start with 600% Higher Market Cap Per Team MemberIntroduction Tevogen Bio Holdings Inc. (Nasdaq: T...
|
| Per Share |
Current |
| Earnings (TTM) |
-0.36 $ |
| Revenues (TTM) |
-
|
| Cash Flow (TTM) |
0 $ |
| Cash |
0.01 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.36 $
|
| Revenues (TTM) |
- |
| Cash Flow (TTM) |
0 $ |
| Cash |
0.01 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
14.34%